37 results
8-K
EX-99.1
INSM
Insmed Incorporated
8 May 23
Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, “The
7:45am
on the path to become one of the next great, sustainable biotechnology companies. Driven by our highly skilled, industry-leading research teams, we
8-K
EX-99.2
INSM
Insmed Incorporated
8 May 23
Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, “The
7:45am
to double one-time in a bioreactor CHALLENGES Relatively slow growth Requires transfection Expensive bioreactors and media Need for maintenance and skilled
424B5
iu10131
5 May 20
Prospectus supplement for primary offering
5:29pm
424B5
yf67 i1tw
22 Jan 18
Prospectus supplement for primary offering
12:00am